Safety and efficacy of long-term oral anticoagulation in cancer patients
- 1 March 1987
- Vol. 59 (5) , 983-985
- https://doi.org/10.1002/1097-0142(19870301)59:5<983::aid-cncr2820590522>3.0.co;2-o
Abstract
The course of long-term oral anticoagulation in 25 patients (186 patient-months) with cancer managed in an outpatient anticoagulation clinic was analyzed to determine the frequency of complications. Major and minor hemorrhagic complications occurred in 10.7% and 32% of treatment courses, respectively, for an incidence of 1.6% and 4.8%, respectively, per patient-month. Recurrent thromboembolism occurred in 14% of treatment courses. These results are better than previous reports in the literature, but worse than our overall anticoagulation clinic experience. Patients with cancer requiring anticoagulation are at a higher risk of hemorrhagic and thrombotic complications. Accordingly, we recommend that such patients be monitored closely, preferrably by physicians experienced with such therapy, as in an anticoagulation clinic, to avoid an excessive degree of morbidity. Cancer 59:983-985, 1987.This publication has 5 references indexed in Scilit:
- Management of Oral Anticoagulant TherapyArchives of internal medicine (1960), 1984
- Management of oral anticoagulant therapy. Experience with an anticoagulation clinicArchives of internal medicine (1960), 1984
- Anticoagulation therapy for venous thromboembolism in patients with gynecologic malignancyAmerican Journal of Obstetrics and Gynecology, 1983
- Anticoagulants, Venous Thromboembolism, and the Cancer PatientArchives of Surgery, 1981
- Alterations of Hemostasis Associated With Malignancy: Etiology, Pathophysiology, Diagnosis and ManagementSeminars in Thrombosis and Hemostasis, 1978